RxDoctor Payments Data

Joseph Simoneau, MD

Family Medicine · Easley, SCNPI 1144600255

Payments from drug & device makers

$2,703in general payments, 2019–2025

Across 168 payments — averaging $16.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$661
  • Lilly USA, LLC$534
  • GSK$275
  • AstraZeneca$243
  • Pfizer$140
  • Astellas Pharma US Inc$132
  • plus $718 from 18 others

What the payments were for

  • Food & beverage$2,703100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,703 in reported general payments places this provider in the 75th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$99,803
Medicare patients
226
Services billed
2,117

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide45$65,638
JardianceEmpagliflozin47$51,485
OzempicSemaglutide38$48,549
EliquisApixaban32$34,063
FarxigaDapagliflozin Propanediol22$23,334
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$22,384
XareltoRivaroxaban19$22,138
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$14,976
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$7,054
TrulancePlecanatide12$6,549
TradjentaLinagliptin12$5,927
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$3,644
Atorvastatin Calcium388$3,639
Albuterol Sulfate HfaAlbuterol Sulfate74$2,444
Gabapentin143$2,236

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$534$65,63845 claims
Boehringer IngelheimJardiance, Tradjenta$120$57,41259 claims
Novo NordiskOzempic$661$48,54938 claims
AstraZenecaFarxiga, Breztri Aerosphere$243$38,31039 claims
PfizerEliquis$140$34,06332 claims
GSKTrelegy Ellipta$275$22,38422 claims
Johnson & JohnsonXarelto$17$22,13819 claims
AbbVieSynthroid$54$99217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Easley

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →